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Eﬀect of Breed on Plasma Endothelin-1 Concentration, Plasma Renin
Activity, and Serum Cortisol Concentration in Healthy Dogs
K. H€oglund, A.-S. Lequarre, I. Ljungvall, K. Mc Entee, A.-C. Merveille, M. Wiberg, V. Gouni,
J. Lundgren Willesen, S. Hanas, G. Wess, L. Mejer Sørensen, L. Tiret, M. Kierczak, S.K.G. Forsberg,
E. Sepp€al€a, K. Lindblad-Toh, H. Lohi, V. Chetboul, M. Fredholm, and J. H€aggstr€om
Background: There are breed diﬀerences in several blood variables in healthy dogs.
Objective: Investigate breed variation in plasma endothelin-1 (ET-1) concentration, plasma renin activity, and serum cor-
tisol concentration.
Animals: Five-hundred and thirty-one healthy dogs of 9 breeds examined at 5 centers (2–4 breeds/center).
Methods: Prospective observational study. Circulating concentrations of ET-1 and cortisol, and renin activity, were mea-
sured using commercially available assays. Absence of organ-related or systemic disease was ensured by thorough clinical
investigations, including blood pressure measurement, echocardiography, ECG, blood and urine analysis.
Results: Median ET-1 concentration was 1.29 (interquartile range [IQR], 0.97–1.82) pg/mL, median cortisol concentration
46.0 (IQR, 29.0–80.8) nmol/L, and median renin activity 0.73 (IQR, 0.48–1.10) ng/mL/h in all dogs. Overall, breed diﬀerences
were found in ET-1 and cortisol concentrations, and renin activity (P < .0001 for all). Pair-wise comparisons between breeds
diﬀered in 67% of comparisons for ET-1, 22% for cortisol, and 19% for renin activity, respectively. Within centers, breed
diﬀerences were found at 5/5 centers for ET-1, 4/5 centers for cortisol, and 2/5 centers for renin activity. Newfoundlands had
highest median ET-1 concentration, 3 times higher than Cavalier King Charles Spaniels, Doberman Pinschers, and Dachs-
hunds. Median renin activity was highest in Dachshunds, twice the median value in Newfoundlands and Boxers. Median cor-
tisol concentration was highest in Finnish Lapphunds, almost 3 times higher than in Boxers.
Conclusions and Clinical Importance: Breed variation might be important to take into consideration when interpreting test
results in clinical studies.
Key words: Biomarker; Breed variation; Canine; Vasoactive.
Regulation of blood pressure is complex involvingbrain, kidneys, cardiovascular system, and vasoac-
tive peptides. Decrease in blood pressure activates the
sympathetic nervous system, the renin-angiotensin-
aldosterone system (RAAS), and vasopressin, leading to
vasoconstriction.1 Angiotensin II can stimulate the
release of endothelin-1 (ET-1), a potent vasoconstrictor,
from vascular endothelium, and ET-1 can in turn stimu-
late the release of norepinephrine, angiotensin II, and
vasopressin.2,3 The RAAS, together with vasopressin,
also stimulates sodium and ﬂuid retention.1 This might
be counteracted by the natriuretic peptides, which
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stimulate natriuresis, diuresis, and vasodilation.1 The
systems are also activated in development of cardiac
and renal disease and several of these substances have
been suggested as biomarkers of disease in dogs.4–6
However, many physiologic and pathologic factors
might inﬂuence neuroendocrine concentrations,5,7,8
making interpretation of test results diﬃcult. Dog breed
is one potential such factor.9
In an European research project, LUPA, over 500
dogs of 9 breeds were examined at ﬁve centers looking
for genetic determinants of variation in blood pressure,
neuroendocrine, and metabolic variables.10 Simultane-
ously, breed diﬀerences in physiological variables were
investigated. Results have shown substantial breed dif-
ferences in plasma concentrations of the natriuretic pep-
tides pro-ANP 31-67 and NT-proBNP,11 prompting
cautiousness when using them as biomarkers for heart
disease. When investigating a subpopulation of the
dogs, we also found breed diﬀerences in blood pressure
and heart rate in consistency with other studies,12–14
and in urinary epinephrine and norepinephrine concen-
trations.15
It has been hypothesized that plasma ET-1 in horses
could be increased in stress conditions and there are
breed diﬀerences in plasma ET-1 and serum cortisol
concentrations.16 The aim of this study was to investi-
gate breed variation in plasma concentration of ET-1,
plasma renin activity, and serum concentration of corti-
sol in healthy dogs.
Materials and Methods
Animals
Dogs were examined at 5 centers: University of Liege, Belgium;
University of Copenhagen, Denmark; National Veterinary School
of Alfort, France; University of Helsinki, Finland; and Swedish
University of Agricultural Sciences, Sweden. The study was per-
formed as part of the EU-funded LUPA-project,10 and was
approved by an ethical committee in each participating country.
Dogs were privately owned, and informed owner consent was
obtained. To be included, dogs had to be pure-bred, healthy, and
1–7 years old. Dogs had to have a normal body condition score,
and could not be related to each other at parental level. Each cen-
ter could include 2–5 breeds, and within center, each breed cohort
included dogs of 1 sex only, intact males, or females that were
spayed or in anestrus, according to LUPA inclusion criteria. Dogs
were excluded if any ﬁnding indicating systemic or organ-related
disease was observed during the clinical examination described
below.
Preparations
To ensure consistent salt intake, owners were instructed to feed
their dog only commercial dog food and no treats, 2 weeks before
participation in the study. On examination day, all dogs were
fasted ≥12 hours and had no access to water for at least 2 hours
before examination.
Characterization of Health Status
From each dog, a morning urine sample collected by the owner
was brought into clinic. Standard urine analysis was performed by
dipstick chemistry test, and refractometer for urine speciﬁc gravity.
The dog underwent general physical examination including blood
pressure measurement by high-deﬁnition oscillometry, according to
published guidelines.17 Each dog was assigned a body condition
score on a 1–9 points scale.18 Five-minute ECG recording and
echocardiographic examination including 2-dimensional, M-mode,
and Doppler echocardiography was performed. The echocardio-
graphic examination was performed from right and left sides,
using standardized imaging planes19 and continuous ECG moni-
toring. Blood was collected after health examination by venipunc-
ture into 5-mL serum and EDTA tubes. In most dogs, blood
sampling was performed between 9 am and 2 pm (n = 499), while
a few dogs (n = 32, 6% of total number of dogs) were sampled
between 2 and 5 pm. Routine hematology and biochemistry analy-
ses including parameters of liver and kidney function, glucose, and
serum electrolyte concentrations were performed. All examinations
were performed in unsedated dogs.
Analyses of ET-1, Renin Activity, and Cortisol
EDTA tubes for analysis of ET-1 concentration and renin activ-
ity, and serum tubes for analysis of cortisol concentration, were
centrifuged within 30 minutes of sample collection. Plasma and
serum were harvested, transferred into plastic cryotubes, frozen
and stored at 80°C. For practical reasons, at 1 center samples
were stored at 20°C for maximum 2 weeks, after which they
were transferred frozen to 80°C and stored for batched analysis.
All samples were later transported frozen on dry ice at 80°C to 2
laboratories, 1 laboratorya for analysis of renin activity and ET-1,
and another laboratoryb for analysis of cortisol.
All analyses were performed using commercially available
assays validated for dogs,20–22 according to manufacturers’
instructions. Renin activity was measured by radioimmunoassay
(RIA) with solid-phase-coated tube separation,c ET-1 by ELISAd
and cortisol by enzyme-linked ﬂuorescent assay (ELFA).e All
samples were analyzed in duplicate by personnel blinded to dog
identity, and mean values were used for data analysis. In-house
duplicate coeﬃcients of variation (CVs) were: renin activity
13.8%, ET-1 7.6%, and cortisol 10.5%. Interassay CVs were:
renin activity < 15%, ET-1 < 10%, and cortisol < 12%. Dynamic
ranges were: renin activity 0.17–3.40 ng/mL/h, ET-1 0.39–50 pg/
mL, and cortisol 5.5–2,759 nmol/L; and limits of detection were:
renin activity 0.010 ng/mL/h, ET-1 0.23 pg/mL, and cortisol
5.5 nmol/L.
Statistical Analyses
Commercially available softwaref was used for statistical analy-
ses. Data are presented as medians and interquartile ranges (IQR).
A value of P < .05 was considered signiﬁcant, unless otherwise
indicated.
The nonparametric Kruskal–Wallis test was used to investigate
overall diﬀerences among breeds for renin activity, ET-1, and cor-
tisol, respectively. If a signiﬁcant diﬀerence was detected, pair-wise
breed comparisons were performed by Mann–Whitney U-test with
Bonferroni adjustment; signiﬁcance level P < .0014.
Due to the uneven breed distribution between centers, breed
was highly covariate with center. Kruskal–Wallis test was therefore
also used to investigate breed diﬀerences within each center for
renin activity, ET-1, and cortisol, respectively. At centers including
more than 2 breeds, pair-wise breed comparisons were performed
by Mann–Whitney U-test with Bonferroni adjustment, if an over-
all signiﬁcant diﬀerence was detected.
Univariate regression analyses were performed to evaluate
potential associations between breed, age, body weight, examina-
tion center, and renin activity, ET-1, and cortisol, respectively. A
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subanalysis of the same variables by univariate regression analysis
was performed in Labrador retrievers, because this breed included
the largest number of dogs, was represented at 4 of 5 centers and
included both female and male dogs. Therefore, sex also was
assessed by univariate regression analysis in the Labrador retriever
breed.
To compensate for inﬂuence of other confounding factors on
renin activity, ET-1, and cortisol, multiple regression analysis was
performed, including variables that reached P < .2 in the univari-
ate regression analysis of all dogs. Analyses were performed in a
reverse stepwise manner,23 starting with all included variables and
removing the variable with highest P-value until all remaining
variables had a P-value <.05. All variables were assessed only as
main eﬀects; no interaction terms were considered in the model.
Distribution of residuals in the multiple regression analysis was
tested for normality using Shapiro–Wilk W test. The adjusted R2
is deﬁned as the percentage of the total sum of squares that can
be explained by the regression and also considers the degrees of
freedom for variables added. Univariate and multiple regression
analyses were performed on log-transformed data. No multiple
regression analysis was performed in the Labrador retriever cohort
due to high covariance between center and sex.
Results
In total, 531 dogs of 9 breeds were included. Twenty-
six examined dogs were excluded due to the following
reasons: myxomatous mitral valve disease (n = 10), tri-
cuspid dysplasia (n = 2), aortic stenosis (n = 3),
arrhythmia (n = 1), hepatopathy (n = 1), signs of
inﬂammation on blood panel (n = 1), isosthenuria
(n = 1), underweight (n = 1), obesity (n = 1), poor con-
dition (n = 1), nonfasted at examination (n = 1), on
medication at examination (n = 1), extreme stress dur-
ing examination (n = 1), character of dog (aggression)
(n = 1). Distribution of breeds and dogs included at dif-
ferent centers is shown in Table 1. Each center exam-
ined dogs belonging to 2–4 breeds and some breeds
were examined at more than 1 center. One breed, the
Labrador retriever, was represented at 4 of 5 centers.
Sex distribution was uneven with 413 males and 118
female dogs (Table 1). All males were intact, whereas
females were spayed or in anestrus. Median age
(n = 531) was 3.3 (IQR, 2.6–4.4) years and median
body weight (n = 490) was 30.0 (IQR, 23.5–36.0) kg.
ET-1, Renin Activity, and Cortisol
Median ET-1 concentration (n = 506) was 1.29 (IQR,
0.97–1.82) pg/mL, median cortisol concentration
(n = 528) was 46.0 (IQR, 29.0–80.8) nmol/L, and med-
ian renin activity (n = 528) was 0.73 (IQR, 0.48–1.10)
ng/mL/h. The number of missing samples was n = 25
for ET-1, n = 3 for cortisol, and n = 3 for renin activ-
ity. Concentrations of ET-1 and cortisol, and renin
activity by breed are shown in Fig 1 and Table 2.
Group-wise Comparisons, All Dogs. Overall signiﬁcant
breed diﬀerences were found for ET-1 and cortisol con-
centrations, and renin activity (P for all < .0001). Pair-
wise breed comparisons showed signiﬁcant diﬀerences
for 24 of 36 comparisons (67%) for ET-1, 8 of 36 com-
parisons (22%) for cortisol, and 7 of 36 comparisons
(19%) for renin activity (Table 3). Concentration of
ET-1 was highest in Newfoundlands with a median con-
centration more than 3 times higher than median values
in Cavalier King Charles Spaniels (CKCS), Doberman
Pinschers and Dachshunds, which had lowest concen-
trations. Renin activity was highest in Dachshunds with
a median value twice the values in Boxers and New-
foundlands, which had the lowest activities. Cortisol
concentration was highest in Finnish Lapphunds with a
median almost 3 times higher than in Boxers, which
had the lowest concentration (Fig 1).
Group-wise Comparisons, Within Center. Overall sig-
niﬁcant breed diﬀerences were found at 5 of the 5 cen-
ters for ET-1 (P ≤ .030), at 4 centers for cortisol
(P ≤ .043), and at 2 centers for renin activity
(P ≤ .0002). Pair-wise comparisons showed signiﬁcant
diﬀerences in 8 of 16 comparisons of ET-1, 5 of 15
comparisons of cortisol, and 4 of 4 comparisons of
renin activity.
Univariate Regression Analysis, All Dogs. The uni-
variate regression analysis of all dogs showed association
between ET-1 and breed (R2 = 0.39, P < .0001), as well
as center of examination (R2 = 0.24, P < .0001). Cortisol
was associated with breed (R2 = 0.08, P < .0001) and
center of examination (R2 = 0.09, P < .0001), and renin
activity with breed (R2 = 0.07, P < .0001) and center of
examination (R2 = 0.02, P = .013). ET-1 increased with
increasing body weight (R2 = 0.14, P < .0001) and renin
activity decreased with increasing body weight
(R2 = 0.02, P = .0009). Age was not associated with any
of the 3 examined substances.
Univariate Regression Analysis, Labrador Retriev-
ers. The univariate regression analysis of Labrador
retrievers showed association between center of exami-
nation and cortisol (R2 = 0.19, P < .0001) as well as
renin activity (R2 = 0.14, P = .0003), whereas ET-1 was
not associated with center of examination. Sex, age, and
bodyweight were not associated with renin activity, ET-
1, or cortisol.
Multiple Regression Analysis, All Dogs. In the multi-
ple regression analysis for ET-1, only breed (P < .0001)
remained signiﬁcant in the ﬁnal model with an adjusted
Table 1. Distribution of dogs by center of examina-
tion, breed, and sex.
Belgium Denmark Finland France Sweden Total
Box 15M 15
BS 95M 25M 121
CKCS 34M 34
Dach 26M 16M 42
Dob 24M 23
FinL 50M 50
GS 16M 60M 76
Lab 6M 45F 29F 46M 126
NF 44F 44
Total 117 89 136 78 111 531
Box, Boxer; BS, Belgian Shepherd; CKCS, Cavalier King
Charles Spaniel; Dach, Dachshund; Dob, Doberman pinscher;
FinL, Finnish Lapphund; GS, German Shepherd; Lab, Labrador
retriever; NF, Newfoundland; M, male; F, female.
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model R2 of 0.39. For cortisol, multiple regression anal-
ysis conﬁrmed an eﬀect of breed (P < .0001) and center
of examination (P < .0001) with an adjusted model R2
of 0.14. For renin activity, breed (P < .0001) and center
of examination (P = .0002) remained signiﬁcant in the
ﬁnal model, which had an adjusted model R2 of 0.11.
Discussion
Results of this study demonstrate that ET-1 can be
included among vasoactive substances that diﬀer
between breeds, whereas breed diﬀerence was smaller
for renin activity. There are breed diﬀerences in concen-
trations of natriuretic peptides and catecholamines in
the same healthy dogs.11,15 Several of these substances
are altered in development of cardiac or renal disease
and have been investigated as potential biomarkers for
disease in dogs.4–6,8,24 A clinically useful test requires an
upper reference limit for healthy dogs, and cut-oﬀ val-
ues for dogs with subclinical disease or clinical signs of
disease.
Endothelin-1 is mainly produced in vascular endothe-
lial cells and acts locally as a potent vasoconstrictor,
but it is also produced in organs such as the heart and
kidney.2,25 In dogs, increased concentrations of ET-1
have been found in chronic kidney disease and ET-1
has been suggested a biomarker of hypertension.6 In
one study, plasma concentrations of ET-1 were twice as
high in dogs with congestive heart failure compared to
controls,26 and studies indicate that ET-1 could aid in
distinguishing between cardiac and noncardiac causes of
dyspnea in dogs.5,8 ET-1 has also been suggested an
useful predictor of poor prognosis in dogs with dilated
cardiomyopathy.4 In that study, ET-1 concentrations
were 3 times higher in dogs with overt dilated car-
diomyopathy compared to controls. Among included
breeds in this study, Newfoundlands had the highest
median ET-1 concentration with values more than 3
times higher than median values in CKCS, Doberman
Pinschers, and Dachshunds. In our previous study of
natriuretic peptide concentrations in the same popula-
tion of dogs, interestingly, Newfoundlands were found
to have the highest and Dachshunds the lowest
NT-proBNP concentration.11 ET-1 has been shown to
directly induce BNP transcription in cultured ventricu-
lar myocytes27, and ET-1 has also been suggested to be
involved in increased synthesis of natriuretic peptides in
dogs with congestive heart failure.28
In this study, RAAS activation was evaluated by
measurement of renin activity. Renin release is stimu-
lated by decrease in arterial blood pressure, decrease in
sodium chloride concentration and ﬂow in the nephron,
and increase in sympathetic nervous activity.29 The
RAAS is activated in cardiac and renal disease and
blockers of diﬀerent components of RAAS are used
therapeutically for both cardiac and renal disease in
dogs.20,30,31 Despite an overall signiﬁcant breed diﬀer-
ence, signiﬁcant diﬀerences were found in less than a
ﬁfth of pair-wise comparisons, and within only 2 of the
centers. It was primarily one breed which diﬀered from
the others in renin activity, namely the Dachshunds
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Fig 1. Boxplots showing distribution of endothelin-1 (A), cortisol
(B), and renin activity (C) by breed. The top, bottom, and line within
each box correspond to the 75th percentile (top quartile), the 25th
percentile (bottom quartile), and the 50th percentile (median), respec-
tively. The whiskers extend from the bottom 2.5th percentile to the
top 97.5th percentile. Outliers, represented by black dots, were
included in statistical analyses. There was an overall signiﬁcant breed
diﬀerence for all 3 substances (P < .0001). For information on which
breeds that diﬀered signiﬁcantly, see Table 3. Box, Boxer; BS, Bel-
gian Shepherd; CKCS, Cavalier King Charles Spaniel; Dach, Dachs-
hund; Dob, Doberman pinscher; FinL, Finnish Lapphund; GS,
German Shepherd; Lab, Labrador retriever; NF, Newfoundland.
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which had the highest activity. The same breed had the
lowest NT-proBNP concentration of all breeds,11 and a
low median ET-1 concentration. Newfoundlands, on
the other hand, had low renin activity and high ET-1 as
well as NT-proBNP concentration.11 Natriuretic pep-
tides are known to suppress RAAS activation in dogs
as well as people,32,33 and ET-1 has been suggested to
inhibit renin production, but the interaction between
hormonal systems is complex.34 Taken together, the
present results indicate that if ET-1 and natriuretic pep-
tides are high, the renin activity is low and vice versa.
Why Dachshund and Newfoundlands had opposite
response patterns is currently unknown. Further study
into the interplay between these substances in healthy
dogs and in dogs with cardiac and renal disease is war-
ranted to optimize their use as biomarkers of disease.
Dogs in the LUPA project all underwent a thorough
standardized health examination. Although attempts
were made to stress dogs as little as possible, in a sub-
population of dogs examined at one center, we found
substantial increases in urine epinephrine and nore-
pinephrine postexamination compared to pre-examina-
tion in home environment, indicating that dogs
experienced stress or excitement during travel and
Table 2. Median, interquartile range (IQR), minimum (min) and maximum (max) values for endothelin-1 and corti-
sol concentrations, and renin activity displayed by breed.
Breed
Endothelin-1 (pg/mL) Cortisol (nmol/L) Renin Activity (ng/mL/h)
Median (IQR) Min–Max Median (IQR) Min–Max Median (IQR) Min–Max
Box 1.68 (1.27–2.42) 1.05–2.92 31.5 (20.3–40.3) 13.0–97.0 0.52 (0.48–0.79) 0.24–1.06
BS 1.07 (0.88–1.41) 0.39–4.18 39.0 (26.0–65.0) 6.0–321 0.73 (0.52–1.11) 0.05–2.33
CKCS 0.89 (0.68–1.24) 0.37–1.77 39.0 (32.0–60.5) 13.0–105 0.84 (0.55–1.14) 0.16–1.76
Dach 1.04 (0.73–1.30) 0.44–2.68 41.0 (26.0–50.5) 9.0–205 1.16 (0.73–1.66) 0.11–3.01
Dob 0.92 (0.63–1.24) 0.23–1.63 37.5 (32.3–72.3) 19.0–103 0.64 (0.45–0.83) 0.01–2.49
FinL 1.61 (1.17–2.01) 0.23–5.58 85.0 (52.0–127) 17.0–253 0.61 (0.23–0.83) 0.01–1.76
GS 1.36 (1.06–1.78) 0.41–2.66 55.0 (28.5–96.5) 9.0–250 0.73 (0.47–1.08) 0.17–3.40
Lab 1.51 (1.11–1.90) 0.38–3.46 45.0 (30.0–88.8) 6.0–271 0.74 (0.48–1.16) 0.01–2.69
NF 3.40 (2.62–4.02) 1.01–5.95 63.5 (37.0–89.8) 12.0–198 0.56 (0.33–0.86) 0.07–1.80
Box, Boxer; BS, Belgian Shepherd; CKCS, Cavalier King Charles Spaniel; Dach, Dachshund; Dob, Doberman pinscher; FinL, Finnish
Lapphund; GS, German Shepherd; Lab, Labrador retriever; NF, Newfoundland.
Table 3. Pair-wise comparisons between breeds in endothelin-1 and cortisol concentrations, and renin activity.
Box CKCS Dach Dob FinL GS Lab NF
BS * * * * * Endothelin-1
* Cortisol
* Renin activity
Box * * * * Endothelin-1
* * Cortisol
* Renin activity
CKCS * * * * Endothelin-1
* Cortisol
Renin activity
Dach * * * * Endothelin-1
* * Cortisol
* * * * * Renin activity
Dob * * * * Endothelin-1
* Cortisol
Renin activity
FinL * Endothelin-1
* Cortisol
Renin activity
GS * Endothelin-1
Cortisol
Renin activity
Lab * Endothelin-1
Cortisol
Renin activity
Box, Boxer; BS, Belgian Shepherd; CKCS, Cavalier King Charles Spaniel; Dach, Dachshund; Dob, Doberman pinscher; FinL, Finnish
Lapphund; GS, German Shepherd; Lab, Labrador retriever; NF, Newfoundland.
The asterisks denote signiﬁcant diﬀerences using a Bonferroni corrected P-value of <.0014.
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examination at the clinic.15 We also found breed diﬀer-
ences in the 2 catecholamines, with lower concentrations
in Labrador retrievers compared to CKCS and Dachs-
hunds.15 In this study, we analyzed cortisol concentra-
tion in serum samples taken from all dogs after the
clinical examination. The observation that breed diﬀer-
ences were found within 4 of the 5 centers indicates that
diﬀerences in handling of the dogs between centers
could not be the sole explanation. In contrast to the
catecholamines, no breed diﬀerences were shown
between CKCS, Dachshunds, and Labrador retrievers.
Instead, cortisol concentration was highest in Finnish
Lapphunds with median concentration almost 3 times
higher than median concentration in Boxers, which had
the lowest concentration. However, although statisti-
cally signiﬁcant, the actual breed diﬀerence in cortisol
concentration was comparatively small and variation
within breeds substantial. The individual stress response
might vary and other factors than breed might be more
relevant for an individual dog in the clinical situation.
Other physiologic factors, which might inﬂuence
concentration of vasoactive peptides, include sex and
age.35,36 Due to the uneven sex distribution among
centers as well as breeds, sex was not included in the
univariate or multiple regression analyses of all dogs,
but was instead assessed in the univariate regression
analysis of the Labrador retriever cohort. No associa-
tion was found between sex and ET-1 concentration,
cortisol concentration, or renin activity. This study
was, however, not designed to evaluate sex diﬀerences
and no multiple regression analysis was performed in
the Labrador retriever cohort, due to the high covari-
ance between center and sex. Age was not associated
with any of the 3 investigated substances, neither
including all dogs nor in the Labrador retriever cohort.
This was not surprising, as the study only included
young adult to middle-aged dogs and was not designed
to evaluate age diﬀerences. Age and sex diﬀerences
have been shown for cortisol and components of
RAAS in dogs.37–39 Age and sex diﬀerences have been
shown for ET-1 in people,40,41 whereas scarce informa-
tion is available for dogs. Additional study into the
eﬀect of sex and age on investigated variables in dogs
is warranted.
Study Limitations
Breed diﬀerences in ET-1 concentration were highly
signiﬁcant within all 5 centers. However, the study only
included 9 breeds and cannot be considered representa-
tive of the entire dog population. Because of the uneven
sex representation and narrow age span of included
dogs, results should not be interpreted as reference val-
ues. To establish breed-speciﬁc reference values, studies
evaluating additional breeds with an even sex and age
representation would have to be performed. Breed dif-
ferences were found at 2 centers for renin activity and
at 4 centers for cortisol concentration. For the latter 2
substances, the diﬀerent number of individuals of each
breed and the uneven breed distribution among centers
could have played a role because the variation was
small compared to ET-1. Furthermore, within-dog vari-
ation in the substances have not been tested, and could
have aﬀected the results.
Sample handling was standardized, but samples were
kept frozen at 20°C for a short time at 1 of the 5 cen-
ters. Stability has been shown at the freezing tempera-
tures used for cortisol in dogs and for plasma renin
activity in people.42,43 Stability of ET-1 has not been
investigated in dogs, but in one human study, ET-1 was
stable at 80°C, but showed degradation when stored
at 30°C for 3 weeks.44 Center of examination did not
aﬀect ET-1 concentration in the multiple regression
analysis of all dogs or in the univariate regression anal-
ysis of the Labrador retriever cohort, where this center
was included. Hence, it is unlikely that sample handling
had any major eﬀect on the results.
The interassay variabilities in this study were good
(<10%) to acceptable (<15%), and should therefore
not have had any major eﬀect on the results. Another
factor which could aﬀect results is time-to-time varia-
tion. In dogs, circadian variation has been shown for
serum cortisol45 and plasma renin activity,46 but has
not been investigated for plasma ET-1. In a small
human study, time-to-time variation in ET-1 was
found.47 To account for circadian variation, blood
sampling was performed between 0900 and 1400 hours
in this study. However, for practical reasons 6% of the
dogs were instead sampled between 1400 and
1700 hours, which could have had a minor eﬀect on
the results. Further study into time-to-time variation in
ET-1 in dogs is warranted.
In order to avoid excessive salt intake, dogs were fed
only commercial dog foods and no treats for 2 weeks
preceding examination. However, as salt content might
vary between food brands, salt intake between dogs
could not be standardized which might have aﬀected
plasma renin activity. Dogs had no access to water for
at least 2 hours before examination in order not to
aﬀect urine density measurements and assessment of
renal function. According to newly published human
recommendations,48 water should be allowed during the
fasting period for most plasma/serum blood tests and
the ingested volume of water should mirror the usual
daily ingested water volume of each individual. How-
ever, urine density as well as hematocrit was within ref-
erence range for all participating dogs and water
restriction should therefore not have had any major
eﬀect on the results.
Conclusion
Breed variation was considerable in circulating ET-1,
but less prominent for circulating cortisol and renin
activity in healthy dogs. Evidence for breed variation in
yet another vasoactive peptide highlights the need for
deeper understanding of their role in health and disease.
Furthermore, breed variation might be important to
take into consideration when interpreting test results in
clinical studies.
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